IP Library Granted Patent US 7,083,966
Granted Patent B2
US 7,083,966 · App. 10/884,878 · Granted Aug 1, 2006

Cytidine deaminase

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,083,966
App. No.
10/884,878
Granted
Aug 1, 2006
Kind
B2
Abstract

Genes encoding novel proteins named AID (Activation-Induced cytidine Deaminase) are described. The AID proteins are structurally related to APOBEC-1, an RNA editing enzyme, and have a cytidine deaminase activity similar to APOBEC-1. The AID genes were found by preparing cDNA libraries from mouse B cell clone CH12F3-2 (which undergoes class switch recombination from IgM to IgA at an extremely high rate after activation of the cells by stimulation with cytokines), with and without stimulation with cytokines, and performing subtraction cloning using the libranes.

Claims (7)

1. A substantially pure polypeptide comprising a fragment of SEQ ID NO:8, wherein the fragment has a cytidine deaminase activity.

2. A substantially pure polypeptide that is at least 95% identical to SEQ ID NO:8, wherein the polypeptide has a cytidine deaminase activity.

3. A substantially pure polypeptide encoded by a nucleic acid comprising a nucleotide sequence that is at least 95% identical to the coding sequence of SEQ ID NO:7, wherein the polypeptide has a cytidine deaminase activity.

4. A substantially pure polypeptide encoded by a nucleic acid that hybridizes to a probe, the sequence of which consists of the complement of the coding sequence of SEQ ID NO:7, in 0.9% NaCl at 75° C., wherein the polypeptide has a cytidine deaminase activity.

5. A substantially pure polypeptide comprising an amino acid sequence wherein 1 to 10 amino acids in the amino acid sequence of SEQ ID NO:8 are substituted, deleted, and/or modified, or an amino acid sequence where 1 to 10 amino acids are added to the amino acid sequence of SEQ ID NO:8, wherein the polypeptide has a cytidine deaminase activity.

6. A substantially pure polypeptide comprising the amino acid sequence of SEQ ID NO:8.

7. A substantially pure polypeptide consisting of the amino acid sequence of SEQ ID NO:8.

Assignments (9)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 5, 2005
From: KANSAI TECHNOLOGY LICENSING ORGANIZATION CO., LTD.
To: HONJO, TASUKU
Reel/Frame 016468/0736 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 5, 2005
From: TAKEDA PHARMACEUTICAL COMPANY, LIMITED
To: MASAMICHI MURAMATSU
Reel/Frame 016468/0793 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 5, 2005
From: HONJO, TASUKU; MURAMATSU, MASAMICHI
To: KYOTO UNIVERSITY
Reel/Frame 016468/0830 →
CORRECTIVE ASSIGNMENT TO ADD A MISSING ASSIGNEE'S NAME, PREVIOUSLY RECORDED AT 015331 FRAME 0306. Recorded Mar 2, 2005
From: KANSAI TECHNOLOGY LICENSING ORGANIZATION CO., LTD.
To: KANSAI TECHNOLOGY LICENSING ORGANIZATION CO., LTD.; TAKEDA CHEMICAL INDUSTRIES, LTD.
Reel/Frame 015816/0538 →
CORRECTIVE ASSIGNMENT TO ADD AN ASSIGNEE'S NAME, PREVIOUSLY RECORDED AT REEL 015268 FRMAE 0352. Recorded Mar 2, 2005
From: HONJO, TASUKU
To: HONJO, TASUKU; TAKEDA CHEMICAL INDUSTRIES, LTD.
Reel/Frame 015816/0495 →
CHANGE OF NAME Recorded Jan 26, 2005
From: TAKEDA CHEMICAL INDUSTRIES, LTD.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 015623/0635 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2004
From: KANSAI TECHNOLOGY LICENSING ORGANIZATION CO., LTD.
To: TAKEDA CHEMICAL INDUSTRIES, LTD.
Reel/Frame 015331/0308 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 2004
From: MURAMATSU, MASAMICHI
To: KANSAI TECHNOLOGY LICENSING ORGANIZATION CO., LTD.
Reel/Frame 015268/0260 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 2004
From: HONJO, TASUKU
To: TAKEDA CHEMICAL INDUSTRIES, LTD.
Reel/Frame 015268/0352 →